TIMP3 Protein To Slow Drusen Formation and Braille and Its History

 

Dr. Ruchira Singh (University of Rochester - Rochester, NY)

Dr. Robert Englebretson (Rice University - Houston, TX)

Dr. Ruchira Singh, Deans Professor Of Ophthalmology, of the University of Rochester in New York, explains how the protein, TIMP3, can slow drusen formation in treating age-related macular degeneration.

Then, Dr. Robert Englebretson, Associate Professor, Director of Undergraduate Studies in Linguistics, at Rice University in Houston discusses braille and the history of many tactile writing systems.

12/1/2024 Podcast (Click Image Below)

Seeing AI's Find My Things Feature and Wavelength Treatment For Myopia Being Treated

Saqib Shaikh (Microsoft - Redmond, WA)

Dr. Safal Khanal (University of Alabama at Birmingham - Birmingham, AL)

Saqib  Shaikh, Founder and Lead of Seeing AI for Microsoft, explains the object finding function, Find My Things, of the Seeing AI app.

Dr. Safal Khanal, Assistant Professor in Department of Optometry and Vision Science, at the University of Alabama at Birmingham, explains a wavelength treatment being tested for children with myopia.

11/24/2024 Podcast (Click Image Below)

Discrimination Against Guide Dog Users By Uber and Lyft and Testing Of Valacyclovir In Treatment of Shingles-Related Eye Problems

Chris Danielsen (National Federation of the Blind - Baltimore, MD)

Dr. Elisabeth Cohen (NYU Grossman School of Medicine - New York, NY)

Chris Danielsen, Director Of Public Relations, for the National Federation Of The Blind in Baltimore, discusses how guide dog users have been denied rides from ride-sharing services, Uber and Lyft.

Then, Dr. Elisabeth Cohen, Professor in the Department of Ophthalmology, at New York University Grossman School of Medicine at NYU Langone Health, explains how a drug, valacyclovir (Valtrex), is being tested to treat eye complications resulting from shingles.

 

11/10/2024 (Click Image Below)